Immunoassay

The quantitative measurement of cardiac troponin I concentration

Pathfast hs-cTnI is a chemi-luminescent enzyme immunoassay (CLEIA) for the quantitative measurement of cardiac troponin I (cTnI) concentration in whole blood or plasma at the point-of-care (POC).

Photo
Pathfast hs-cTnI chemi-luminescent enzyme immunoassay
Source: Mitsubishi

Reagents are single use in all-in-one cartridges and up to six tests in parallel can be analysed,’ the manufacturer Mitsubishi reports. ‘Low concentrations of cTnI can be analysed by using high sensitivity cardiac troponin (hs-cTnI) assays that meet the criteria for high sensitivity defined by IFCC and ESC.’ 

Pathfast provides high accuracy and precision of test results similar to central lab analyser, combined with the flexibility of a POCT assay within 17 minutes out of whole blood and plasma by an all-in-one cartridge solution, Mitsubishi confirms. ‘In clinical studies Pathfast hs-cTnI has been evaluated for a 99th percentile upper reference limit of 29.0 ng/L at an imprecision of 6.1%, which is less than 10%, and fits for the criteria of hs-cTnI, declared by IFCC. 

‘Moreover, gender specific 99th cut off values were identified and 0/1 hour Rule-out and Rule-in algorithms of NSTEMI for Pathfast could be established. In large validation cohorts the NPVs for rule-out of NSTEMI exceeded 98%. For Pathfast hs-cTnI, cut off levels have been examined for 669 patients with suspected NSTEMI and NPVs between 98.9% and 100%. The PPVs for rule-in obtained from validation cohorts meet the rule-in criteria of 75-80%.

‘Cut off values with PPVs between 75.2% and 78.6% have been identified and troponin values could be determined above the limit of detection in 66.3% of healthy individuals. Pathfast assays show no biotin interference since utilised monoclonal antibodies are alkaline phosphatase conjugated instead.’


Mitsubishi is at ESC!

Hall 7, Level 2, K200

31.08.2019

Read all latest stories

Related articles

Photo

Covid-19 detection

New blood test measures immunity against SARS-CoV-2 and its variants

The Lausanne University Hospital (CHUV) and EPFL teamed up to develop a new test that’s sensitive enough to measure the amount of SARS-CoV-2 neutralizing antibodies present in the bloodstream. The…

Photo

High-sensitivity troponin I assay

Speeding up diagnosis of myocardial infarction

The new generation troponin I assay unveiled by Beckman Coulter is helping improve heart attack diagnosis. Delivering high sensitivity, and rapid result turnaround times, every element of the Access…

Photo

Cardiac troponin I concentration measured at POC

Triage aided by a quick sensitive test

Large proportions of patients can be safely triaged either to rule out discharge or rule in lifesaving management – if following the European Society of Cardiology (ESC) Guidelines Class I…

Related products

Lifotronic - FA-160 Immunofluorescence Analyzer

Other

Lifotronic - FA-160 Immunofluorescence Analyzer

Lifotronic Technology Co., Ltd
Beckman Coulter – Access Procalcitonin (PCT)

Immunoassays

Beckman Coulter – Access Procalcitonin (PCT)

Beckman Coulter, Inc.
FUJIFILM Wako - μTASWako i30

Immunoassays

FUJIFILM Wako - μTASWako i30

Wako Chemicals GmbH
Genrui – FA50

Immunoassays

Genrui – FA50

Genrui Biotech Inc.